Ischemic Stroke Market Report and Forecast 2025-2034

Ischemic Stroke Market Outlook

The ischemic stroke market size is expected to grow at a CAGR of 5.2% during the forecast period of 2025-2034, driven by the rising prevalence of ischemic stroke risk factors such as hypertension, diabetes, obesity, and sedentary lifestyle across the 8 major markets.

Ischemic Stroke Market Overview

Ischemic stroke occurs due to blockage in the arteries that supplies blood to the brain. This type of stroke accounts for 87%  of all strokes and causes damage to the brain cells. A recent study estimated the global age-standardized incidence rate of ischemic stroke is expected to increase to 89.32 per 100,000 individuals by 2030, with the projections indicating a higher occurrence in women than  men. This rising incidence of the condition is anticipated to drive the ischemic stroke market growth in the near future.

In August 2023 , Enspire DBS Therapy, Inc., secured USD 17.6 million in Series B funding led by Cleveland Clinic Innovations to support the development of its deep brain stimulation (DBS) and rehabilitation therapy for stroke patients. The funds will be primarily utilized for the clinical trial RESTORE, which aims to investigate DBS and rehab therapy’s efficacy in treating chronic upper extremity impairment due to stroke and generate sufficient data for market approval. A previous trial known as EDEN (Electrical Stimulation of the Dentate Nucleus for Upper Extremity Hemiparesis Due to Ischemic Stroke) showed positive results that prompted the Series B raise. Such investments in innovative neuro-stimulation solutions address a specific clinical need and are expected to fuel the ischemic stroke market demand in the forecast period.

The market is also driven by the growing preference for non-invasive procedures to treat and manage ischemic stroke. Moreover, the rise in public health campaigns and heightened patient awareness will fuel market growth.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Ischemic Stroke Market Trends

Ischemic Stroke Market Segmentation

Market Breakup by Indication Type

• Large Artery Thrombosis (LAT)

• Cardioembolic Stroke

• Lacunar Stroke

• Cryptogenic Stroke

The market is segmented by indication type into large artery thrombosis (LAT), cardioembolic stroke, lacunar stroke, and cryptogenic stroke. LAT involves major artery blockage whereas cardioembolic strokes are caused by clots originating in the heart.

Market Breakup by Diagnosis Type

• Imaging Techniques (MRI, CT Scans, and Angiography)

• Blood Tests

• Electrocardiography (ECG/EKG)

The market segmentation by diagnosis type for ischemic stroke comprises imaging techniques (MRI, CT scans, and angiography) to visualize brain structures and blood vessels, blood tests for biomarker analysis, and electrocardiography (ECG/EKG) to detect heart abnormalities.

Market Breakup by Treatment Type

• Thrombolytic Therapy

• Endovascular Procedures

• Anticoagulants & Antiplatelet Drugs

• Neuroprotective Agents

• Rehabilitation Therapies

• Surgical Interventions

By treatment type, the ischemic stroke market share includes thrombolytic therapy, endovascular procedures, anticoagulants and antiplatelet drugs, neuroprotective agents, rehabilitation therapies, along with surgical interventions. Thrombolytic therapy is used to dissolve clots and endovascular procedures are carried out for clot removal. Anticoagulants and antiplatelet drugs help to prevent clot formation.

Market Breakup by End User

• Hospitals and Clinics

• Ambulatory Surgical Centres (ASCs)

• Rehabilitation Centres

End users of the market are hospitals and clinics, ambulatory surgical centers (ASCs), and rehabilitation centers.

Market Breakup by Region

• United States

• EU-4 and the United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom

• Japan

• China

Based on the region, the market includes the United States, EU-4 (Germany, France, Italy, Spain), the United Kingdom, Japan, and China. The United States dominates the market share, which can be attributed to a well-developed research infrastructure, which further boosts the treatment landscape. Asia Pacific is poised to witness significant growth, owing to rising investments from public and private institutions, aimed at improving the healthcare infrastructure.

Ischemic Stroke Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Medtronic plc

• Genentech, Inc.

• GE Healthcare

• Covidien plc

• Cordis Corporation

• Boston Scientific Corporation

• Boehringer Ingelheim

• Bayer AG

• Abbott Laboratories

• Johnson & Johnson

• Swiss Pharma Pvt. Ltd.

• Bristol Myers Squibb

• Pfizer

• Eli Lilly and Company

• GlaxoSmithKline

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report

Key Queries Solved in the Ischemic Stroke Market Report

• How has the ischemic stroke market performed so far and how is it expected it perform in coming years?
• What are the major market trends influencing the market? 
• What will be the effect of each driver, challenge, and opportunity on the market? 
• Which regional market is expected to dominate the market share in the forecast period? 
• Which country is expected to experience rapid growth during the forecast period? 
• How does the prevalence and incidence of ischemic stroke affect the market landscape?
• How does the rise in the geriatric population impact the ischemic stroke market value?
• What treatment type of ischemic stroke will dominate the market share? 
• Which diagnostic method is expected to have a high market value in the coming years?
• Which indication type will cover a significant portion of the market segment?
• How will the ongoing clinical trials impact the market value during the forecast period? 
• What are the factors driving regional disparities in ischemic stroke treatment and outcomes?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, and mergers & acquisitions among the key market players shaping the market dynamics?